| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
58,160,000 |
| Market
Cap: |
5.82(B) |
| Last
Volume: |
5,449,206 |
Avg
Vol: |
5,434,465 |
| 52
Week Range: |
$99.99 - $99.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Spector Steven W |
VP, General Cousel & Secretary |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$1,499 |
D/D |
294 |
42,376 |
|
- |
|
| Williams Joyce H |
VP, Drug Development |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
80,448 |
|
- |
|
| Beeley Nigel R A |
VP, Chief Chemical Officer |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
84,657 |
|
- |
|
| Mooney Joseph F |
Chief Financial Officer |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$1,714 |
D/D |
336 |
27,161 |
|
- |
|
| Maffuid Paul W |
VP, Pharmaceutical Development |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$826 |
D/D |
162 |
16,106 |
|
- |
|
| Hoffman Robert |
Vice President, Finance |
• – – |
2003-09-30 |
4 |
A |
$5.10 |
$377 |
D/D |
74 |
51,859 |
|
- |
|
| Lief Jack |
President and CEO |
• • – |
2003-09-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
581,258 |
|
- |
|
| Maffuid Paul W |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$903 |
D/D |
177 |
15,944 |
|
- |
|
| Spector Steven W |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$1,499 |
D/D |
294 |
42,082 |
|
- |
|
| Williams Joyce H |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
79,823 |
|
- |
|
| Hoffman Robert |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$377 |
D/D |
74 |
51,785 |
|
- |
|
| Beeley Nigel R A |
officerTitle |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
84,032 |
|
- |
|
| Lief Jack |
officerTitle |
• • – |
2003-06-30 |
4 |
A |
$5.10 |
$3,188 |
D/D |
625 |
580,633 |
|
- |
|
| Mooney Joseph F |
Chief Financial Officer |
• – – |
2003-06-30 |
4 |
A |
$5.10 |
$1,591 |
D/D |
312 |
26,825 |
|
- |
|
| Behan Dominic P |
SVP & Chief Scientific Officer |
• • – |
2001-04-30 |
5 |
AS |
$19.59 |
$24,488 |
D/D |
(1,250) |
317,500 |
|
- |
|
415 Records found
|
|
Page 17 of 17 |
|
|
